Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...
A woman with a vision issue experienced terrifying hallucinations - seeing images of alien faces, demons and animals. Alison ...
Alison Henthorne, 59, was diagnosed after two major eye operations to fix a detached retina left her with blind spots ...
Richmond town crier Tracy Spencer, 55, has described how a vigilant Specsavers optician saved her sight after a routine eye ...
Alison Henthorne, 59, said she even asked a priest to bless her and the house after seeing scary 'spaceships and alien' ...
Richmond town crier Tracy Spencer, 55, has described how a vigilant Specsavers optician saved her sight after a routine eye test - prompted ...
The transfer from Texas scored 17 points in the Syracuse women's basketball team's exhibition win over Daemen.
Stories by SWNS on MSN
Rare vision syndrome led woman to see “demons and aliens” in scary hallucinations
A woman suffering a rare vision problem experienced terrifying hallucinations – seeing images of alien faces, demons and ...
Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay and should be managed appropriately. Retinal Vasculitis and/or Retinal Vascular ...
13d
Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...
In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback